» Articles » PMID: 11453923

Successful Treatment of Cutaneous Langerhans Cell Histiocytosis with Low-dose Methotrexate

Overview
Journal Br J Dermatol
Specialty Dermatology
Date 2001 Jul 17
PMID 11453923
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Langerhans cell histiocytosis (LCH) can be a difficult therapeutic problem. We present a 40-year-old woman with a 4-year history of LCH who was successfully treated with low-dose methotrexate (20 mg weekly).

Citing Articles

Vulvar Langerhans cell histiocytosis: Clinicopathologic characteristics, mutational profile, and treatment of 4 patients in a single-center cohort.

Renier R, De Haes P, Bosisio F, Vanden Bempt I, Woei-A-Jin F JAAD Case Rep. 2023; 36:78-81.

PMID: 37250013 PMC: 10220460. DOI: 10.1016/j.jdcr.2023.03.024.


International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults.

Goyal G, Tazi A, Go R, Rech K, Picarsic J, Vassallo R Blood. 2022; 139(17):2601-2621.

PMID: 35271698 PMC: 11022927. DOI: 10.1182/blood.2021014343.


Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders.

Papo M, Cohen-Aubart F, Trefond L, Bauvois A, Amoura Z, Emile J Curr Oncol Rep. 2019; 21(7):62.

PMID: 31115724 DOI: 10.1007/s11912-019-0810-6.


Cervical langerhans cell histiocytosis mimicking cervical tuberculosis: A Case report.

Rao J, Rao Y, Wang C, Cai Y, Cao G Medicine (Baltimore). 2019; 98(20):e15690.

PMID: 31096509 PMC: 6531057. DOI: 10.1097/MD.0000000000015690.


Langerhans cell histiocytosis in adults: Advances in pathophysiology and treatment.

Kobayashi M, Tojo A Cancer Sci. 2018; 109(12):3707-3713.

PMID: 30281871 PMC: 6272080. DOI: 10.1111/cas.13817.